Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918383 · ClinicalTrials.gov registry record · NA
Subchondral Perfusion Mapping Using Indocyanin Green Laser
A NA study, sponsored by Loma Linda University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02918383: Clinical Trial NA study, sponsored by Loma Linda University.
NCT02918383 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02918383, a NA study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Laser Angiography using indocyanin green (ICG) is a relatively new technique and has been utilized to assess the viability of soft tissue, most prominently in the general surgery and plastic surgery literature. This technique has been used for prediction of soft tissue viability by assessing the perfusion status. There is currently no Orthopaedic literature regarding the use of this device for assessment of subchondral perfusion of articular surfaces such as the distal femur or other chondral surfaces. In this pilot study, the use of ICG to detect the perfusion status of a distal femur and proximal tibia during a surgical approach to the knee and correlating this to visible signs of arthritis. For example, due to the difference visible with ICG angiography correlate to gross changes in the cartilage health visible to the naked eye with radiographic imaging.
Primary Outcome
Visible grade of chondromalacia from the 6 points mentioned above. * Video will be acquired using the Spy Elite or Pinpoint system of the distal femur or proximal tibial surface. Currently, the software with the SPY elite is able to quantify the degree of dye uptake, and this dye uptake number from the 6 points will also be recorded. * Video data will be given a key that corresponds to the subject, thus no videos will be labelled with patient data or information chondromalacia ondromalacia from
Interventions
- DIAGNOSTIC_TEST Indocyanin Green Dye (ICG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-12 |
| Phase | NA |
Why NCT02918383 stopped before completion
NCT02918383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Indocyanin Green Dye (ICG) is the first listed.
NCT02918383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02918383 about?
NCT02918383 is a clinical study titled "Subchondral Perfusion Mapping Using Indocyanin Green Laser". Laser Angiography using indocyanin green (ICG) is a relatively new technique and has been utilized to assess the viability of soft tissue, most prominently in the general surgery and plastic surgery literature. This technique has been used for prediction of soft tissue viability by assessing the per...
What is the current status of trial NCT02918383?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-06. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02918383?
The interventions under investigation include: Indocyanin Green Dye (ICG) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02918383?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02918383's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia